Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061516
Status:
COMPLETED
Last Update Posted:
2016-11-18
First Post:
2003-05-28
Brief Title:
Safety and Efficacy Study of BETAXON 05 and AZOPT 10 in Pediatric Patients With Glaucoma or Ocular Hypertension
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
Safety and Efficacy Study of BETAXON 05 and AZOPT 10 in Pediatric Patients With Glaucoma or Ocular Hypertension
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of both BETAXON and AZOPT in pediatric patients Patients will dose with study drug at 8 am and 8 pm daily for twelve weeks Patients will have vision tested slit lamp exam blood pressure and pulse checks at each visit Patients will have a dilated fundus exam and corneal measurements taken at first and last visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None